TenNor Therapeutics Ltd   Report issue

For profit Phase 2
Founded: Westfield NJ United States (2013)

Organization Overview

First Clinical Trial
2019
NCT03964493
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

TenNor Therapeutics Limited

Active Ingredients

Drugs in Phase 2 Trials (2)

tnp-2092 (3 trials)

vancomycin (Vancocin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bacterial Infections (Phase 2)

Communicable Diseases (Phase 2)

Gram-Positive Bacterial Infections (Phase 2)

Infections (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 2